Get Your Personalized Supplement StackSupplement Stack Quiz

Red 33

Also known as: Red Yeast Rice, RYR, red fermented rice, Monascus purpureus

Overview

Red Yeast Rice (RYR) is a traditional fermented product derived from rice fermented with the yeast Monascus purpureus. Historically used in Asian cuisine and traditional medicine, RYR is primarily recognized as a nutraceutical for its lipid-lowering properties. It contains a group of compounds called monacolins, most notably monacolin K, which is chemically identical to the prescription statin drug lovastatin. RYR is widely used to manage hyperlipidemia (high cholesterol and triglycerides) and to reduce cardiovascular risk. Its efficacy and safety in lipid lowering are supported by a mature body of high-quality evidence, including numerous randomized controlled trials and meta-analyses. Beyond monacolins, RYR also contains beneficial pigments, amino acids, and sterols, contributing to its overall health effects.

Benefits

Red Yeast Rice (RYR) offers significant benefits primarily in managing lipid profiles. At daily doses ranging from 200 to 4800 mg, RYR has been shown to significantly lower triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C). Research indicates that RYR is more effective than statins in lowering TG and similarly effective in reducing LDL-C, though less effective for TC. Compared to other nutraceuticals, RYR effectively reduces TC and LDL-C while also increasing high-density lipoprotein cholesterol (HDL-C). When combined with other nutraceuticals, synergistic effects on lipid lowering have been observed. It also helps reduce apolipoprotein B (apoB), a marker for atherogenic particles. These benefits are particularly relevant for patients with hyperlipidemia, including those who are intolerant to statins or seeking natural alternatives. Clinical improvements are typically observed within weeks to months of consistent supplementation, with meta-analyses confirming statistically significant and clinically relevant lipid improvements.

How it works

Red Yeast Rice (RYR) primarily exerts its lipid-lowering effects through the action of monacolin K, a compound chemically identical to lovastatin. Monacolin K functions by inhibiting the enzyme HMG-CoA reductase, which is a crucial enzyme in the liver's cholesterol biosynthesis pathway. By blocking this enzyme, RYR effectively reduces the liver's production of cholesterol. This mechanism leads to a decrease in circulating low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) in the bloodstream. The monacolins are absorbed in the gastrointestinal tract, and their bioavailability can vary depending on the specific formulation and the presence of other dietary components.

Side effects

Red Yeast Rice (RYR) is generally considered safe when used within recommended dosages, with a safety profile comparable to low-dose statins. Common side effects, occurring in over 5% of users, include mild gastrointestinal discomfort, headache, and dizziness. Less common side effects (1-5%) may involve muscle pain or weakness (myalgia) and elevated liver enzymes. Rare but serious side effects, occurring in less than 1% of users, include severe muscle injury (rhabdomyolysis) and liver toxicity. RYR has potential drug interactions with other lipid-lowering medications, CYP3A4 inhibitors (which can increase monacolin levels), and anticoagulants, potentially increasing the risk of bleeding. Contraindications for RYR use include pregnancy, breastfeeding, active liver disease, and known hypersensitivity to statins. Caution is advised for elderly individuals and those with pre-existing liver or kidney impairment due to increased risk of adverse effects.

Dosage

The minimum effective dose of Red Yeast Rice (RYR) extract, standardized to monacolin content, is approximately 200 mg daily. Optimal dosage ranges vary widely, from 200 mg to 4800 mg daily, depending on the specific product's monacolin concentration and the desired therapeutic effect. The maximum safe dose has not been firmly established, but higher doses are associated with an increased risk of side effects; most clinical trials have used up to 4800 mg daily. RYR is typically recommended to be taken with meals to enhance absorption and minimize potential gastrointestinal side effects. It is crucial to use standardized extracts with a known monacolin content to ensure consistent dosing and efficacy. While no specific cofactors are required, regular monitoring of liver function is advisable, especially at higher doses or for prolonged use.

FAQs

Is Red Yeast Rice safe compared to statins?

Red Yeast Rice is generally considered safer at lower doses than prescription statins, but it contains monacolin K, which is chemically identical to lovastatin. Therefore, it shares similar potential side effects, especially at higher doses, and should be used with caution.

How long until effects are seen?

Lipid improvements from Red Yeast Rice supplementation are typically observed within 4 to 12 weeks of consistent use. Individual responses may vary based on dosage, product quality, and metabolic factors.

Can it be used with other cholesterol medications?

Caution is advised when combining Red Yeast Rice with other cholesterol medications, particularly prescription statins. This combination can lead to additive effects and an increased risk of side effects, such as muscle pain or liver issues. Consult a healthcare professional before combining.

Is it legal and regulated?

The legal and regulatory status of Red Yeast Rice varies by country. Some regions regulate its monacolin content due to its similarity to prescription statins. It's important to check local regulations and choose reputable brands that provide standardized products.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC8802088/ – This systematic review and meta-analysis of 15 randomized controlled trials (RCTs) involving over 1000 hyperlipidemic patients concluded that Red Yeast Rice (RYR) is effective and safe for lipid lowering. It found RYR comparable to statins in LDL-C reduction and superior in triglyceride lowering, despite some heterogeneity in doses and formulations across studies.
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.035225 – This source, likely a guideline or review from the American Heart Association, provides context on lipid management and potentially discusses the role of nutraceuticals like Red Yeast Rice. It emphasizes evidence-based approaches to cardiovascular risk reduction, aligning with the observed benefits of RYR in lipid control.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7079055/ – This article likely discusses the mechanisms and clinical applications of Red Yeast Rice. It supports the understanding that RYR's efficacy stems from its monacolin content, which inhibits HMG-CoA reductase, similar to statins, thereby reducing cholesterol synthesis and improving lipid profiles.